Colony Group’s Ginkgo Bioworks DNA Stock Holding History

Colony Group’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$19K	Hold	260	–	–	﹤0.01%	753
2023 Q2	$19K	Hold	260	–	–	﹤0.01%	759
2023 Q1	$14K	Hold	260	–	–	﹤0.01%	781
2022 Q4	$18K	Hold	260	–	–	﹤0.01%	829
2022 Q3	$32K	Hold	260	–	–	﹤0.01%	767
2022 Q2	$25K	Hold	260	–	–	﹤0.01%	811
2022 Q1	$42K	Buy	+260	New	+$50.6K	﹤0.01%	833

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Colony Group's DNA Position: Q3 2023 in Review

Colony Group held its Ginkgo Bioworks (DNA) position steady in Q3 2023 at 260 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #753.

Colony Group first reported a position in DNA in Q1 2022 and has held it in 7 quarters since. The position peaked at $42K in Q1 2022. 349 funds tracked by Wall St. Rank hold DNA as of Q3 2023.

Colony Group held 260 shares of Ginkgo Bioworks worth $19K as of Q3 2023.
Colony Group left its Ginkgo Bioworks share count unchanged in Q3 2023.
Ginkgo Bioworks made up ﹤0.01% of Colony Group's portfolio in Q3 2023, its #753 holding.
Colony Group first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 7 quarters since.
Colony Group's Ginkgo Bioworks position peaked at $42K in Q1 2022.
349 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.